
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10594400
[patent_doc_number] => 09315476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Antiviral water-soluble product with anti-HIV effect, based on ionic silver and methylene blue compound; method of its production and examples of HIV-infected patients\' treatment'
[patent_app_type] => utility
[patent_app_number] => 14/680577
[patent_app_country] => US
[patent_app_date] => 2015-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3855
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14680577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/680577 | Antiviral water-soluble product with anti-HIV effect, based on ionic silver and methylene blue compound; method of its production and examples of HIV-infected patients' treatment | Apr 6, 2015 | Issued |
Array
(
[id] => 10325676
[patent_doc_number] => 20150210680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'AMINODIHYDROTHIAZINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/679666
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67209
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679666
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/679666 | AMINODIHYDROTHIAZINE DERIVATIVES | Apr 5, 2015 | Abandoned |
Array
(
[id] => 11873543
[patent_doc_number] => 09745300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Organic compounds'
[patent_app_type] => utility
[patent_app_number] => 15/301895
[patent_app_country] => US
[patent_app_date] => 2015-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14322
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301895
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301895 | Organic compounds | Apr 2, 2015 | Issued |
Array
(
[id] => 10325712
[patent_doc_number] => 20150210716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'BACE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/677113
[patent_app_country] => US
[patent_app_date] => 2015-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22423
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14677113
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/677113 | BACE inhibitors | Apr 1, 2015 | Issued |
Array
(
[id] => 10587642
[patent_doc_number] => 09309244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Compound useful for the treatment of degenerative and inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 14/677058
[patent_app_country] => US
[patent_app_date] => 2015-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24750
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14677058
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/677058 | Compound useful for the treatment of degenerative and inflammatory diseases | Apr 1, 2015 | Issued |
Array
(
[id] => 13653803
[patent_doc_number] => 09853224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Fluorescent organic light emitting elements having high efficiency
[patent_app_type] => utility
[patent_app_number] => 15/301863
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9855
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 309
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301863 | Fluorescent organic light emitting elements having high efficiency | Mar 29, 2015 | Issued |
Array
(
[id] => 10354853
[patent_doc_number] => 20150239857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => '(THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/673614
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 46677
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14673614
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/673614 | (Thio)morpholine derivatives as S1P modulators | Mar 29, 2015 | Issued |
Array
(
[id] => 10312508
[patent_doc_number] => 20150197510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'Arylethynyl derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/669653
[patent_app_country] => US
[patent_app_date] => 2015-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5054
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14669653
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/669653 | Arylethynyl derivatives | Mar 25, 2015 | Issued |
Array
(
[id] => 11762958
[patent_doc_number] => 09371317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-21
[patent_title] => 'Sweet flavor modifier'
[patent_app_type] => utility
[patent_app_number] => 14/670202
[patent_app_country] => US
[patent_app_date] => 2015-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18775
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14670202
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/670202 | Sweet flavor modifier | Mar 25, 2015 | Issued |
Array
(
[id] => 10306457
[patent_doc_number] => 20150191457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/666089
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19890
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14666089
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/666089 | Bisaryl (thio)morpholine derivatives as S1P modulators | Mar 22, 2015 | Issued |
Array
(
[id] => 12936643
[patent_doc_number] => 09831449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Light-emitting materials for light-emitting diodes
[patent_app_type] => utility
[patent_app_number] => 15/325701
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 2750
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325701
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325701 | Light-emitting materials for light-emitting diodes | Mar 15, 2015 | Issued |
Array
(
[id] => 10628684
[patent_doc_number] => 09346829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => '5-HT3 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 14/645639
[patent_app_country] => US
[patent_app_date] => 2015-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15258
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645639
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/645639 | 5-HT3 receptor antagonists | Mar 11, 2015 | Issued |
Array
(
[id] => 11750343
[patent_doc_number] => 09708345
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-07-18
[patent_title] => 'Aminothiazine compounds'
[patent_app_type] => utility
[patent_app_number] => 15/115280
[patent_app_country] => US
[patent_app_date] => 2015-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8500
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15115280
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/115280 | Aminothiazine compounds | Mar 4, 2015 | Issued |
Array
(
[id] => 11499131
[patent_doc_number] => 20170073317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'ISOCYANURATE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/123200
[patent_app_country] => US
[patent_app_date] => 2015-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13718
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123200
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/123200 | Isocyanurate composition | Mar 2, 2015 | Issued |
Array
(
[id] => 10281496
[patent_doc_number] => 20150166493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/630458
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15124
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630458 | Arylpiperazine derivatives and methods of utilizing same | Feb 23, 2015 | Issued |
Array
(
[id] => 10281494
[patent_doc_number] => 20150166491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'OXAZINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/627700
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42138
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627700
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/627700 | Oxazine derivatives | Feb 19, 2015 | Issued |
Array
(
[id] => 10272643
[patent_doc_number] => 20150157641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'TETRAHYDROPYRROLOTHIAZINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/626320
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13747
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14626320
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/626320 | TETRAHYDROPYRROLOTHIAZINE COMPOUNDS | Feb 18, 2015 | |
Array
(
[id] => 10290594
[patent_doc_number] => 20150175589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/625928
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 71130
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14625928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/625928 | Phenoxazine derivatives and methods of use thereof | Feb 18, 2015 | Issued |
Array
(
[id] => 11706178
[patent_doc_number] => 20170174677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'TETRAHYDROPYRIDOPYRAZINES MODULATORS OF GPR6'
[patent_app_type] => utility
[patent_app_number] => 15/118447
[patent_app_country] => US
[patent_app_date] => 2015-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22268
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118447
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/118447 | Tetrahydropyridopyrazines as modulators of GPR6 | Feb 12, 2015 | Issued |
Array
(
[id] => 11311655
[patent_doc_number] => 20160347766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'Crystalline Forms of Dolutegravir Sodium'
[patent_app_type] => utility
[patent_app_number] => 15/114991
[patent_app_country] => US
[patent_app_date] => 2015-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3249
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114991
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/114991 | Crystalline forms of dolutegravir sodium | Feb 3, 2015 | Issued |